Menarini: Elcin Barker Ergun Group CEO - 12 September 2019 23:05

FLORENCE, Italy, September 12, 2019, /PRNewswire-AsiaNet/-- The Board of Directors has appointed Mrs. Elcin Barker Ergun as CEO of Menarini Group. "Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas," commented Eric...

  Strekin AG Announces Completion of Patient Recruitment in the ... - 12 September 2019 16:15

BASEL, Switzerland, Sept.12, 2019 /PRNewswire-AsiaNet/ -- Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase ...

  Mindray launches the new BeneHeart C Series AED to enhance res... - 12 September 2019 10:00

SHENZHEN, China, Sept. 12, 2019 /PRNewswire-AsiaNet/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, today launched the BeneHeart C Series automated external defibrillator (AED) with smarter operations and faster shock delivery to achieve better res...

  deCODE in Iceland agrees to sequence half of UK Biobanks parti... - 12 September 2019 01:55

REYKJAVIK, Iceland, 11. September, 2019/PRNewswire-AsiaNet/ -- deCODE in Iceland agrees to sequence half of UK Biobanks participants deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to u...

  Merck Announces FDA Breakthrough Therapy Designation for Inves... - 11 September 2019 16:30

DARMSTADT, Germany, Sept. 11, 2019 /PRNewswire-AsiaNet/ -- - Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications are present in 3-5% of non-small cell lung cancer patients and correlate ...

  Emergency Nurses Association Launches New International Digita... - 10 September 2019 12:00

SCHAUMBURG, Illinois, Sept. 10, 2019 /PRNewswire-AsiaNet/ -- - ENA aims to develop global alliance through networking and educational opportunities The Emergency Nurses Association ( https://c212.net/c/link/?t=0&l=en&o=2572382-1&h=4139880866&u=https%3A%2F%2Fwww.ena.or...

  Updated Results for Investigational Therapy Tepotinib Presente... - 09 September 2019 22:29

DARMSTADT, Germany, Sept. 9, 2019 /PRNewswire-AsiaNet/-- - Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study - Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epid...

  Newly Published ROSacea COnsensus (ROSCO) Expert Recommendatio... - 09 September 2019 18:52

LAUSANNE, Switzerland, September 9, 2019, /PRNewswire-AsiaNet/-- Experts also welcome upsurge in the adoption of a rosacea signs and symptoms ('phenotype') led approach in clinical practice and announce the launch of prototype clinical tools to support physicians to optimize rosacea management Published o...

  SpePharm AG Wins Case Against Eisai Inc. in United States Dist... - 09 September 2019 17:00

AMSTERDAM, Sept. 9, 2019 /PRNewswire-AsiaNet/ -- SpePharm AG, a subsidiary of Norgine B.V., announced that the United States District Court for the District of Delaware ruled on 4th September 2019 in favour of SpePharm in its proceeding against Eisai Inc., upholding SpePharm's licensed rights fo...

  Equashield and Tosho Inc. Increase CSTD Adoption in Japan New... - 09 September 2019 09:30

NEW YORK, Sept 9, 2019 /PRNewswire-AsiaNet/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that, through Japanese distributor Tosho Inc. (https://www.tosho.cc/en/), the award-winning EQUASHIELD CSTD will now be ...